Inventor
THOMPSON BRADLEY G
CA144 patents
⚠️ This page may combine multiple inventors who share the name “THOMPSON BRADLEY G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WYVERN PHARMACEUTICALS INC
21 patentsUS12195747B1Jan 14, 2025
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC39 citations98
US12134770B1Nov 5, 2024
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC87 citations98
US12018274B2Jun 25, 2024
Compositions and methods for regulating production of a fusion protein and ribonucleic acid
WYVERN PHARMACEUTICALS INC79 citations98
US11873505B2Jan 16, 2024
Compositions and methods for regulating production of a precursor protein
WYVERN PHARMACEUTICALS INC81 citations98
US11530423B1Dec 20, 2022
Composition for regulating production of ribonucleic acid
WYVERN PHARMACEUTICALS INC83 citations98
US12281306B1Apr 22, 2025
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC7 citations86
US12595484B2Apr 7, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12570979B2Mar 10, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12565655B2Mar 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12565657B2Mar 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12559754B2Feb 24, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12559751B2Feb 24, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12559756B2Feb 24, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12553051B2Feb 17, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12553052B2Feb 17, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12540326B2Feb 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12540328B2Feb 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12540329B2Feb 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12540322B2Feb 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12540327B2Feb 3, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
US12534733B2Jan 27, 2026
Composition for regulating production of interfering ribonucleic acid
WYVERN PHARMACEUTICALS INC0 citations73
ONCOLYTICS BIOTECH INC
21 patentsUS7252817B2Aug 7, 2007
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC28 citations96
US6649157B2Nov 18, 2003
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC51 citations96
US6596268B1Jul 22, 2003
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC51 citations96
US6565831B1May 20, 2003
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC53 citations96
US6528305B2Mar 4, 2003
Method of producing infectious reovirus
ONCOLYTICS BIOTECH INC41 citations96
US7964186B2Jun 21, 2011
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC8 citations93
US7708987B2May 4, 2010
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC14 citations93
US7608257B2Oct 27, 2009
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
ONCOLYTICS BIOTECH INC12 citations93
US7452723B2Nov 18, 2008
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC23 citations93
US7431932B2Oct 7, 2008
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
ONCOLYTICS BIOTECH INC15 citations93
US7306902B2Dec 11, 2007
Oncolytic viruses as phenotyping agents for neoplasms
ONCOLYTICS BIOTECH INC27 citations93
US7264798B2Sep 4, 2007
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
ONCOLYTICS BIOTECH INC27 citations93
US7186542B2Mar 6, 2007
Method of extracting virus from cell culture
ONCOLYTICS BIOTECH INC24 citations93
US7049127B2May 23, 2006
Method of producing infectious reovirus
ONCOLYTICS BIOTECH INC24 citations93
US7014847B2Mar 21, 2006
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC22 citations93
US6994858B2Feb 7, 2006
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
ONCOLYTICS BIOTECH INC25 citations93
US6808916B2Oct 26, 2004
Method of extracting virus from cell culture
ONCOLYTICS BIOTECH INC32 citations93
US7964187B2Jun 21, 2011
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
ONCOLYTICS BIOTECH INC8 citations84
US7198783B2Apr 3, 2007
Sensitization of neoplastic cells to radiation therapy with reovirus
ONCOLYTICS BIOTECH INC11 citations84
US7731951B2Jun 8, 2010
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC7 citations74
US6703232B2Mar 9, 2004
Method of producing infectious reovirus
ONCOLYTICS BIOTECH INC10 citations74
NOVA HUSKY RESEARCH CORP LTD
2 patentsWYVEM PHARMACEUTICALS INC
1 patentALBERTA RES COUNCIL
1 patentSTEM CELL THERAPEUTICS INC
1 patentLEPS WALTER T
1 patentCOFFEY MATTHEW C
1 patentTHOMPSON BRADLEY G
1 patentShowing the top 50 of 144 patents by PatentIndex Score.